FDA
-
-
-
-
-
-
-
Biotech's New Frontier: Companies Breaking Through Medicine's Toughest Barriers
-
-
-
-
-
-
-
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
-
-
-
-
-
-
-
Law firm announces class action lawsuit against uniQure over FDA delay
-
-
-
-
-
-
-
uniQure N.V. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 13, 2026 to Discuss Your Rights - QURE
-
-
-
-
-
-
-
uniQure N.V. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before April 13, 2026 to Discuss Your Rights – QURE
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on uniQure BV (QURE)
-
-
-
-
-
-
-
Cantor Fitzgerald Downgrades uniQure BV (QURE) to Neutral following FDA recommendation
-
325,494 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

